index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral
1 Données de recherche

Open Access

47 %

Mots clés

Dystrophine Calcium handling Gene therapy Mouse GNE RNA interference Errance diagnostique Regeneration Muscular dystrophy Patient registry Acetyltransferase COL1A1 Muscle A-type lamins Muscle biopsy Autophagosome maturation Butyrylcholinesterase BiP CMTX Allele-specific silencing Cardiac conduction system Laminopathy Centronuclear myopathy Hypermobile EDS LMNA-related congenital muscular dystrophy Connective tissue Allele-specific silencing therapy Exome Dystrophie musculaire Biological sciences Myopathy CRISPR Dynamin 2 Base de données FAIR Maladies rares et orphelines Actionability LMNA Heart failure LMNA gene Treatment delay Angiotensin-converting enzyme inhibitor Actionable gene Muscle MRI Laminopathies Lamin A/C Rare neuromuscular diseases Rare diseases Muscular dystrophy MD Lamin A/C nuclei Dilated cardiomyopathy Cancer biomarkers Maladies rares LGMD Myotubes Skeletal muscle Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Myopathies BVES Joint laxity Neuromuscular diseases COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders INPP5K Emery-Dreifuss muscular dystrophy POPDC1 Adult SMA Cardiology Next generation sequencing Lamins Myologie Diagnosis Alternative splicing Cardiomyopathy C2C12 CSF protein A-type lamin Emerin AAV VECTOR COVID-19 Heart Nuclear envelope Treatment Biomarker Titin COL6A1 Lamin A/C LMNA gene IPSC Laminopathie Becker muscular dystrophy Clinical trial Congenital muscular dystrophy Cancer Myogenesis Allele‐specific silencing therapy AAV Mutations Ehlers‐Danlos Syndrome Angiotensin-converting enzyme inhibitors Duchenne muscular dystrophy C elegans Therapy